Clinical Trial Update: An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs

View source ↗

Summary

Completed observational study sponsored by Bayer to evaluate the safety of rivaroxaban in participants with Peripheral Arterial Disease who had surgical procedu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Peripheral Arterial Disease (PAD) | Status: COMPLETED